VLA1553, commercially known as Ixchiq, has received USFDA clearance and will be launched in India — which has seen high number of chikungunya cases — after ‘regulatory talks with DCGI’.----more----Read full article here: https://theprint.in/health/worlds-1st-vaccine-against-chikungunya-primed-for-launch-in-india-says-french-drugmaker-valneva/1846509/